Skip to Content

Glecaprevir / pibrentasvir Disease Interactions

There are 2 disease interactions with glecaprevir / pibrentasvir:


Direct acting antivirals (applies to glecaprevir/pibrentasvir) immunosuppression

Major Potential Hazard, Moderate plausibility. Applicable conditions: Infectious Hepatitis, Immunodeficiency

HBV reactivation has been reported during or after completion of HCV direct-acting antiviral therapy in HCV/HBV-coinfected patients who were not receiving HBV antiviral therapy; some cases resulted in fulminant hepatitis, hepatic failure, and death. Cases have been reported in hepatitis B surface antigen (HBsAg)-positive patients and patients with serologic evidence of resolved HBV infection (i.e., HBsAg negative and hepatitis B core antibody [anti-HBc] positive). HBV reactivation has also been reported in patients using certain immunosuppressant or chemotherapeutic agents; risk of HBV reactivation associated with HCV direct-acting antiviral therapy may be increased in these patients. All patients should be tested for evidence of current or prior HBV infection by measuring HBsAg and anti-HBc before starting HCV direct-acting antiviral therapy. Patients with serologic evidence of current or prior HBV infection should be monitored for clinical and laboratory signs of hepatitis flare or HBV reactivation during HCV therapy and posttherapy follow-up; appropriate patient management for HBV infection should be started as clinically indicated.


Glecaprevir/pibrentasavir (applies to glecaprevir/pibrentasvir) liver dysfunction

Major Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

The use of the co-formulated presentation of glecaprevir and pibrentasvir is contraindicated in patients with moderate or severe hepatic impairment (Child-Pugh B or C) or those with any history of prior hepatic decompensation. No dosage adjustment is required in patients with mild hepatic impairment (Child-Pugh A).

Glecaprevir / pibrentasvir drug interactions

There are 115 drug interactions with glecaprevir / pibrentasvir

Glecaprevir / pibrentasvir alcohol/food interactions

There is 1 alcohol/food interaction with glecaprevir / pibrentasvir

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.